EGFR and neoplasm: Here, we demonstrated that tumour cell proliferation in three different human cancer cell lines (A549, SW837, MCF7) had the potency to be activated by a synchronised and synergetic activation of EGFR or via electrical dipole interactions between tiny size RE-NPs and the LABS of integrins on a cell.